New "Artificial Heart" to Provide Long-term Support for Patients with Heart Failure
Ascenion obtains equity in Dualis MedTech in return for spin-off coaching
Core to Dualis' business model is a new ventricular assist device consisting of a fully implantable mechanical pump and a wireless energy transfer system. It does not replace the natural heart but rather helps a diseased heart to pump blood through the body. Due to a flow-optimized pump, it solves problems of blood-clotting or haemolysis usually associated with mechanical blood pumping. Moreover, it is the first ventricular assist device to allow free movement of the patient and avoid the risk of infection, as there is no extracorporal pump or transcutaneous wire. The small, wireless control and energy supply unit can simply be worn on the belt.
Prototypes of the pump and energy transfer system were manufactured and tested at the Institute of Robotics and Mechatronics of the German Aerospace Center (DLR). In-vitro endurance tests confirmed feasibility and reliability of the approach. Animal studies are scheduled to start this year. In parallel, Dualis intends to outlicence the wireless energy transfer system to manufacturers of active implants with applications outside its own business focus.
Most read news
Other news from the department research and development
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.